The Joint (JYNT)
(Delayed Data from NSDQ)
$16.12 USD
+3.26 (25.35%)
Updated May 3, 2024 04:00 PM ET
After-Market: $16.19 +0.07 (0.43%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth F Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
JYNT 16.12 +3.26(25.35%)
Will JYNT be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for JYNT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for JYNT
The Joint Corp. (JYNT) Beats Q1 Earnings and Revenue Estimates
The Joint Corp. (JYNT) Upgraded to Buy: What Does It Mean for the Stock?
JYNT: What are Zacks experts saying now?
Zacks Private Portfolio Services
The Joint Corp. (JYNT) Moves 10.1% Higher: Will This Strength Last?
The Joint (JYNT) Rises 30% as Q4 Earnings Beat on Higher Clinics
The Joint Corp. (JYNT) Q4 Earnings and Revenues Top Estimates
Other News for JYNT
The Joint Corp (JYNT): Hold Rating Maintained Amidst Transition and Mixed Performance
The Joint Corp. (JYNT) Q1 2024 Earnings Call Transcript
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Joint (JYNT) and Cerus (CERS)
Lake Street Keeps Their Buy Rating on Joint (JYNT)
Joint Corp. price target raised by $3 at Roth MKM, here's why